Good day, everyone, and welcome to the Nucor Corporation Third Quarter of 2012 Earnings Call. As a reminder, today's call is being recorded. Later, we will conduct a question-and-answer session and instructions will come at that time.
Leadership changes and litigation risk should not scare investors away from financials, as quarterly results show that several names are currently a fairly good deal, says Morningstar's Jim Sinegal.
With double-digit increases looming for most Part D premiums, Morningstar columnist Mark Miller urges seniors to examine their options to ensure they are in the optimal drug plan for 2013.